Publications by authors named "Mark Pescovitz"

Claim this Profile
D
Depletion of the chimeric drug Rituximab from biological samples.
Benita K Book, Mark D Pescovitz, Lili Guo, Eric A Wiebke

Hum Immunol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes.
Teresa L Mastracci, Jean-Valery Turatsinze, Benita K Book, Ivan A Restrepo, Michael J Pugia, Mark D Pescovitz

Diabetes Obes Metab· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-lymphocyte depletion with rituximab and β-cell function: two-year results.
Mark D Pescovitz, Carla J Greenbaum, Brian Bundy, Dorothy J Becker, Stephen E Gitelman

Diabetes Care· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.
Halvor Rollag, Thor Ueland, Anders Asberg, Anders Hartmann, Alan G Jardine, Mark D Pescovitz

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total IgA and IgA reactivity to antigen I/II epitopes in HLA-DRB1*04 positive subjects.
V Wallace McCarlie, James K Hartsfield, Janice S Blum, Carlos González-Cabezas, Judith R Chin, Mark D Pescovitz

Open J Immunol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
Jing Lu Kroll, Craig Beam, Shaobing Li, Raphael Viscidi, Bonnie Dighero, Mark Pescovitz

J Clin Virol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome.
Halvor Rollag, Anders Asberg, Thor Ueland, Anders Hartmann, Alan G Jardine, Mark D Pescovitz

Transplantation· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Carla J Greenbaum, Craig A Beam, David Boulware, Stephen E Gitelman, Peter A Gottlieb, Mark D Pescovitz

Diabetes· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.
Bertram L Kasiske, Bjorn Nashan, Maria Del Carmen Rial, Pablo Raffaele, Graeme Russ, Mark D Pescovitz

J Transplant· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes.
John M Lachin, Paula L McGee, Carla J Greenbaum, Jerry Palmer, Mark D Pescovitz

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.
Vincent C Emery, Oriol Manuel, Anders Asberg, Xiaoli Pang, Deepali Kumar, Mark D Pescovitz

J Clin Virol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rituximab on human in vivo antibody immune responses.
Mark D Pescovitz, Troy R Torgerson, Hans D Ochs, Elizabeth Ocheltree, Paula McGee

J Allergy Clin Immunol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes.
Kevan C Herold, Mark D Pescovitz, Paula McGee, Heidi Krause-Steinrauf, Lisa M Spain

J Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.
Yannick Le Meur, Richard Borrows, Mark D Pescovitz, Klemens Budde, Josep Grinyo

Transplant Rev (Orlando)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response.
Luiz F Lisboa, Anders Asberg, Deepali Kumar, Xiaoli Pang, Anders Hartmann, Mark D Pescovitz

Transplantation· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Mark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, Dorothy J Becker, Stephen E Gitelman

N Engl J Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Oriol Manuel, Anders Asberg, Xiaoli Pang, Halvor Rollag, Vincent C Emery, Mark D Pescovitz

Clin Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
Mark D Pescovitz, Nosratollah Nezakatgoo, Marc I Lorber, Bjorn Nashan, Helio Tedesco-Silva

Transplantation· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Guy Boivin, Nathalie Goyette, Halvor Rollag, Alan G Jardine, Mark D Pescovitz

Antivir Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.
Robert P Nelson, Robert M Pascuzzi, Kenneth Kessler, Laurence E Walsh, Phillip P Faught, Mark D Pescovitz

J Clin Neuromuscul Dis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
Brenda C M de Winter, Teun van Gelder, Petra Glander, Dario Cattaneo, Helio Tedesco-Silva, Mark D Pescovitz

Clin Pharmacokinet· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of antibody induction in pediatric renal transplantation.
Mark D Pescovitz

Curr Opin Organ Transplant· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Michal J Figurski, Artur Nawrocki, Mark D Pescovitz, Rene Bouw, Leslie M Shaw

Ther Drug Monit· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients.
Mark D Pescovitz, Stuart Knechtle, Steven R Alexander, Paul Colombani, Tom Nevins

Pediatr Transplant· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay.
David Zhuang, Melinda Smedema, Ann Lemonte, Benita K Book, Mark D Pescovitz

Antimicrob Agents Chemother· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis